Krilov LR - Search Results

1

SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.

Anderson EJ, Krilov LR, DeVincenzo JP, Checchia PA, Halasa N, Simões EA, Domachowske JB, Forbes ML, Pannaraj PS, McBride SJ, McLaurin KK, Kumar VR, Ambrose CS. Anderson EJ, et al. Among authors: krilov lr. Am J Perinatol. 2017 Jan;34(1):51-61. doi: 10.1055/s-0036-1584147. Epub 2016 May 27. Am J Perinatol. 2017. PMID: 27233106 Free article.

2

Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone.

Bonville CA, Mehta PA, Krilov LR, Rosenberg HF, Domachowske JB. Bonville CA, et al. Among authors: krilov lr. Cell Immunol. 2001 Nov 1;213(2):134-40. doi: 10.1006/cimm.2001.1869. Cell Immunol. 2001. PMID: 11831875

3

Palivizumab in the prevention of respiratory syncytial virus disease.

Krilov LR. Krilov LR. Expert Opin Biol Ther. 2002 Oct;2(7):763-9. doi: 10.1517/14712598.2.7.763. Expert Opin Biol Ther. 2002. PMID: 12387675 Review.

4

Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States.

Krilov LR, Palazzi DL, Fernandes AW, Klein RW, Mahadevia PJ. Krilov LR, et al. Value Health. 2010 Jan-Feb;13(1):77-86. doi: 10.1111/j.1524-4733.2009.00586.x. Epub 2009 Aug 24. Value Health. 2010. PMID: 19706010 Free article.

5

Respiratory syncytial virus disease: update on treatment and prevention.

Krilov LR. Krilov LR. Expert Rev Anti Infect Ther. 2011 Jan;9(1):27-32. doi: 10.1586/eri.10.140. Expert Rev Anti Infect Ther. 2011. PMID: 21171875 Review.

6

Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis.

Krilov LR, Masaquel AS, Weiner LB, Smith DM, Wade SW, Mahadevia PJ. Krilov LR, et al. BMC Pediatr. 2014 Oct 13;14:261. doi: 10.1186/1471-2431-14-261. BMC Pediatr. 2014. PMID: 25308481 Free PMC article.

7

Viral Bronchiolitis in Children.

DeVincenzo JP, Krilov LR, Yogev R. DeVincenzo JP, et al. Among authors: krilov lr. N Engl J Med. 2016 May 5;374(18):1791. doi: 10.1056/NEJMc1601509. N Engl J Med. 2016. PMID: 27144865 No abstract available.

8

Confounding by Indication Limits Conclusions of Study of Palivizumab Effectiveness.

Boyce TG, Yogev R, DeVincenzo JP, Krilov LR. Boyce TG, et al. Among authors: krilov lr. Pediatrics. 2017 Mar;139(3):e20164247A. doi: 10.1542/peds.2016-4247A. Pediatrics. 2017. PMID: 28246350 No abstract available.

9

The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.

Kong AM, Krilov LR, Fergie J, Goldstein M, Diakun D, Wade SW, Pavilack M, McLaurin KK. Kong AM, et al. Among authors: krilov lr. Am J Perinatol. 2018 Jan;35(2):192-200. doi: 10.1055/s-0037-1606352. Epub 2017 Sep 7. Am J Perinatol. 2018. PMID: 28881376 Free PMC article.

10

Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value.

Olchanski N, Hansen RN, Pope E, D'Cruz B, Fergie J, Goldstein M, Krilov LR, McLaurin KK, Nabrit-Stephens B, Oster G, Schaecher K, Shaya FT, Neumann PJ, Sullivan SD. Olchanski N, et al. Among authors: krilov lr. Open Forum Infect Dis. 2018 Feb 7;5(3):ofy031. doi: 10.1093/ofid/ofy031. eCollection 2018 Mar. Open Forum Infect Dis. 2018. PMID: 29516023 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters